Sound Income Strategies, LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

Quarter-by-quarter ownership
Sound Income Strategies, LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$21,630
-24.6%
8050.0%0.00%
-33.3%
Q2 2023$28,706
+40.4%
8050.0%0.00%
+50.0%
Q1 2023$20,447
-37.4%
8050.0%0.00%
-50.0%
Q4 2022$32,651
+20.9%
8050.0%0.00%0.0%
Q3 2022$27,000
-3.6%
8050.0%0.00%0.0%
Q2 2022$28,000
-24.3%
8050.0%0.00%0.0%
Q1 2022$37,000
-30.2%
8050.0%0.00%
-33.3%
Q4 2021$53,000
-8.6%
805
-13.4%
0.01%
-14.3%
Q3 2021$58,000
-24.7%
9300.0%0.01%
-36.4%
Q2 2021$77,000
-99.8%
930
+36.8%
0.01%
+37.5%
Q1 2021$45,091,000
+86613.5%
6800.0%0.01%
-27.3%
Q4 2020$52,000
+79.3%
6800.0%0.01%
+37.5%
Q3 2020$29,0000.0%6800.0%0.01%
-11.1%
Q2 2020$29,000
+45.0%
6800.0%0.01%
+28.6%
Q1 2020$20,000
-76.7%
680
-50.0%
0.01%
-53.3%
Q4 2019$86,000
+352.6%
1,360
+100.0%
0.02%
+150.0%
Q3 2019$19,000
-44.1%
680
-47.7%
0.01%
-50.0%
Q2 2019$34,0001,2990.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders